A detailed history of Wcm Investment Management, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Wcm Investment Management, LLC holds 173,984 shares of IMVT stock, worth $4.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
173,984
Previous 175,542 0.89%
Holding current value
$4.79 Million
Previous $4.63 Million 3.28%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$27.51 - $27.51 $42,860 - $42,860
-1,558 Reduced 0.89%
173,984 $4.79 Million
Q2 2024

Jul 31, 2024

BUY
$25.1 - $31.61 $147,512 - $185,771
5,877 Added 3.46%
175,542 $4.63 Million
Q1 2024

Apr 25, 2024

BUY
$30.27 - $43.79 $1.88 Million - $2.73 Million
62,264 Added 57.97%
169,665 $5.48 Million
Q4 2023

Jan 29, 2024

BUY
$31.31 - $44.19 $3.36 Million - $4.75 Million
107,401 New
107,401 $4.52 Million

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Wcm Investment Management, LLC Portfolio

Follow Wcm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.